| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM049934E |
| P698 | PubMed publication ID | 15481972 |
| P50 | author | Gordon Roberts | Q42678035 |
| Jean-Didier Maréchal | Q51070700 | ||
| C Wolf | Q56436390 | ||
| Mike Sutcliffe | Q67276585 | ||
| Mark John Ingraham Paine | Q70912022 | ||
| Carol A Kemp | Q117261255 | ||
| P2093 | author name string | Jack U Flanagan | |
| Annamaria J van Eldik | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | in silico | Q192572 |
| P304 | page(s) | 5340-5346 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Validation of model of cytochrome P450 2D6: an in silico tool for predicting metabolism and inhibition | |
| P478 | volume | 47 |
| Q35827110 | Allelic Variation of Cytochrome P450s Drives Resistance to Bednet Insecticides in a Major Malaria Vector |
| Q51910625 | AmineDB: large scale docking of amines with CYP2D6 and scoring for druglike properties--towards defining the scope of the chemical defense against foreign amines in humans. |
| Q51920384 | CYP2D6 gene test in psychiatric patients and healthy volunteers. |
| Q37921791 | Computational modeling of P450s for toxicity prediction |
| Q58005526 | Computational prediction of drug binding and rationalisation of selectivity towards cytochromes P450 |
| Q42594109 | Free energies of binding of R- and S-propranolol to wild-type and F483A mutant cytochrome P450 2D6 from molecular dynamics simulations |
| Q36985072 | Future directions for drug transporter modelling. |
| Q51019253 | Genotyping of the cytochrome P450 2D6 4469 C>T polymorphism using SimpleProbes. |
| Q45732317 | Heterologous expression of CYP102A5 variant from Bacillus cereus CYPPB-1: Validation of model for predicting drug metabolism of human P450 probe substrates |
| Q37733570 | Human CYPs involved in drug metabolism: structures, substrates and binding affinities |
| Q54484162 | In silico prediction of cytochrome P450 inhibitors |
| Q36572626 | In vitro screening of drug metabolism during drug development: can we trust the predictions? |
| Q36497020 | Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions. |
| Q30378479 | Integrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6. |
| Q56992052 | Metabolism ofN-substituted 7-methoxy-4-(aminomethyl) -coumarins by cytochrome P450 2D6 mutants and the indication of additional substrate interaction points |
| Q36716929 | Methods for predicting human drug metabolism |
| Q34994964 | New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme |
| Q28647980 | Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets |
| Q36906273 | Predicting CYP2C19 catalytic parameters for enantioselective oxidations using artificial neural networks and a chirality code |
| Q54419443 | Predicting the activity and toxicity of new psychoactive substances: a pharmaceutical industry perspective. |
| Q37587216 | QSAR of cytochrome inhibitors |
| Q36543100 | Structure-based methods for the prediction of drug metabolism |
| Q83195004 | The molecular basis for the inhibition of human cytochrome P450 1A2 by oroxylin and wogonin |
Search more.